Going back to their discovery in the early 1980s, both the Human T-cell Leukemia virus type-
1 (HTLV-1) and the Human Immunodeficiency Virus type-1 (HIV-1) greatly fascinated the …

Dendritic cells (DCs) function as a link between innate and adaptive immune responses.
Retroviruses HIV-1 and HTLV-1 modulate DCs to their advantage and utilize them to …

Since the discovery of the human T-cell leukemia virus-1 (HTLV-1), cellular and animal
models have provided invaluable contributions in the knowledge of viral infection …

Human immunodeficiency virus (HIV) and human T-lymphotropic virus type I (HTLV-I) are
two retroviruses that attack the immune cells and impair their functions. Both HIV and HTLV-I …

Aim To perform a systematic review to describe the available findings on clinical outcomes
in HIV-1 and HTLV-1/HTLV-2 co-infected individuals since 1995. Design This Systematic …

HIV-1 is the most prevalent retrovirus, with over 30 million people infected worldwide.
Nevertheless, infection caused by other human retroviruses like HIV-2, HTLV-1, HTLV-2 …

The risk of developing adult T-cell leukemia/lymphoma (ATLL) in individuals infected with
human T-cell lymphotropic virus 1 (HTLV-1) is about 3–5%. The mechanisms by which the …

Early detection of retroviruses including human T-cell lymphotropic virus and human
immunodeficiency virus in the human body is indispensable to prevent retroviral infection …

In the literature, a great number of HIV and HTLV-I mono-infection models has been
formulated and analyzed. However, the within-host dynamics of HIV/HTLV-I co-infection has …

Human T-lymphotropic virus type 1 (HTLV-1) is a retrovirus associated with substantial risk
of secondary (often life-threatening) disease for the estimated 10 million to 20 million people …